Candel Therapeutics, Inc. (CADL) vs Rigel Pharmaceuticals, Inc. (RIGL)
Candel Therapeutics, Inc. and Rigel Pharmaceuticals, Inc. are both Biotechnology companies. Candel Therapeutics, Inc. and Rigel Pharmaceuticals, Inc. are of similar size ($894.6M and $883.8M). Candel Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Rigel Pharmaceuticals, Inc. trades at 2.7×. Rigel Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 3.31% against 0.00%. Rigel Pharmaceuticals, Inc. has the higher net margin (116.3% vs 0.00%) and the higher return on invested capital (16.5% vs 0.00%). Across the 17 metrics below, Rigel Pharmaceuticals, Inc. leads on 16 and Candel Therapeutics, Inc. on 1.
Valuation
Profitability
| Metric | CADL | RIGL | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 91.39% | 65.16% |
| Operating margin | 0.00% | 31.45% | 0.00% |
| Net margin | 0.00% | 116.30% | 0.00% |
| Free cash flow margin | 0.00% | 3.19% | 0.00% |
| Return on equity | (81.84%) | 126.90% | (57.72%) |
| Return on assets | (56.37%) | 88.46% | (49.22%) |
| Return on invested capital | 0.00% | 16.48% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack